Classement en actions
#15689
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Capitalisation boursière
$337.03M
Changement (1 jour)
-0.36%
Changement (1 an)
-28.32%
Le prix ILM1 avec la capitalisation boursière de B
Capitalisation boursière de Medios AG(ILM1)
Capitalisation boursière: $337.03M
En September 2026, Medios AG a une capitalisation boursière de $337.03M. Cela fait de Medios AG la 15689th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Medios AG du 2007 au 2026
ILM1 par rapport au top 5 des plus populaires stocks
| Prix pour ILM1 |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.276T
|
+1,565,467.36%
|
|
|
|
|
$4.775T
|
+1,416,747.11%
|
|
|
|
|
$4.041T
|
+1,199,012.18%
|
|
|
|
|
$3.740T
|
+1,109,595.53%
|
|
|
|
|
$2.745T
|
+814,310.72%
|
